Just Answers - Finance

When it comes to investing your money, you need to understand the relationship between risk and reward. When you assume the risk of inve

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

sting in a stock, you anticipate a reward. The reward should be appropriate given the level of risk you are assuming.

However, the rewa

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

d is just a potential. Due to the risk, there is no certainty.

You should still figure out what your reward should be on an investment.

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

The good news is that it isn't difficult to see if the reward and risk are in line with each other.

Start by determining the "ris

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

-free" return that is currently available on the market. This is the baseline for your reward measurement. Most investors use US Tr

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

asury Bonds as their benchmark -- partly because governments aren't expected to default. For example, a risk-free return from a Treasury

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

bond of 5% could be your baseline. Any investment that has risk must give you a better return than 5%.

The amount of return that you r

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ceive over your baseline of 5% is your risk premium. If you are looking at a stock with an expected return of 10%, you have a risk premi

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

um of 5% on that return.

Then you must decide if the premium is large enough for the risk associated with the particular stock. Keep in

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

mind that the stock may not achieve the return you expect. It depends on the type of stock. Large-cap, well-established stocks are fairl

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

solid bets. New small-cap stocks may have too much risk for the premium to justify them.

When it comes to the analysis you should perf

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

orm on a stock before purchasing it, there are many tests that you should put the stock through. However, it is important to know whethe

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

or not the investment risk premium is worth the risk that the stock places on your portfolio.

You should also keep in mind that your r

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ate of return on a stock is affected by inflation and taxes. When you calculate your rate of return, you must make sure that you are tho

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ough in your calculation. What you are looking for is the real interest rate, not the nominal rate.

The nominal interest rate tells you

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

the growth rate of your money. The real interest rate tells you how much your purchasing power is growing. Your money could increase wit

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

hout seeing an increase in your purchasing power.

For example, if your investment grows by 6% in one year and the rate of inflation for

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

the year is 3%, your real rate of return is only 3% (6-3). If you are depending on dividend income or interest from bonds, you will be a

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ffected by the costs of inflations.

If you hold onto a stock, the gains can build. An $1,000 investment with a nominal rate of 8% can e

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

sily turn into a real rate of 2.6% after inflation and taxes. This is something to consider when planning your portfolio and investments

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justanswers.org.ua/article/116895/justanswers-Calculating-Your-Risk-Premium.html">Calculating Your Risk Premium</a>

BB link (for phorums):
[url=http://www.justanswers.org.ua/article/116895/justanswers-Calculating-Your-Risk-Premium.html]Calculating Your Risk Premium[/url]

The individuals that have been slowest to embrace technology and the Internet are the ones who have the option to use it, as opposed to those of us who are forced to in order to keep up.

What Does A Contract Mean? Contracts refer to the legally binding agreement between two parties when the transaction of any property including money or promises takes place.

Individual Voluntary Arrangement, IVA is an alternative to bankruptcy - which could provide you with a real solution to your debt problems.

Tags

Links

Just Answers - Calculating Your Risk Premium

Related Articles: